Hai-Long Hu (Hailong Hu)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Replacement Therapy

Peritoneal Dialysis

Cross Sectional

Ejection Fraction

Top Venues

Disease markers

Cell transplantation

Cancer medicine

Tianjin Medical University Second Hospital

Tianjin Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tianjin Medical University Second Hospital Oct 01 2014

China

Chief Physician :: The Department of Urology

Education History

Tianjin Medical University Sep 01 2004 - Jun 30 2007

China

PHD :: Surgery

Publications

Yinglang Zhang, Zhi Li, Yu Zhang, Chong Shen, Zhe Zhang, Xiaolei Ren, Changgang Guo, Shaobo Yang, Zejin Wang, Hai-Long Hu
circSOBP Inhibits Bladder Cancer Proliferation and Metastasis by Regulating the miR-200a-3p/PTEN Axis and Participating in the Immune Response. Cell transplantation 32 (2023)
Ruopeng Su, Liangren Liu, Daoping Hong, Shuai Jiang, Yichu Yuan, Xingyun Cai, Hai-Long Hu, Changde Fu, Zhiyang Huang, Zhenyu Wang, Bing Zheng, Jian Huang, Zaoyu Wang, Yige Bao, Ming Cai, Jianming Guo, Minfeng Chen, Qiang Wei, Jiwei Huang, Wei Xue
Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world study. Cancer medicine (2023)
Da-Wei Tian, Zhou-Liang Wu, Li-Ming Jiang, Jie Gao, Chang-Li Wu, Hai-Long Hu
KIF5A Promotes Bladder Cancer Proliferation In Vitro and In Vivo. Disease markers 2019 (2019)